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Abstract: Oxidative stress is associated with obstetric complications during ovarian hyperstimulation
in women undergoing in vitro fertilization. The follicular fluid contains high levels of proteins,
which are the main targets of free radicals. The aim of this work was to determine specific biomarkers
of non-enzymatic oxidative modifications of proteins from follicular fluid in vivo, and the effect of
ovarian stimulation with gonadotropins on these biomarkers. For this purpose, 27 fertile women
underwent both a natural and a stimulated cycle. The biomarkers, glutamic semialdehyde (GSA),
aminoadipic semialdehyde (AASA), Nε-(carboxymethyl)lysine (CML), and Nε-(carboxyethyl)lysine
(CEL), were measured by gas-liquid chromatography coupled to mass spectrometry. Results showed
that follicular fluid contained products of protein modifications by direct metal-catalyzed oxidation
(GSA and AASA), glycoxidation (CML and CEL), and lipoxidation (CML). GSA was the most
abundant biomarker (91.5%). The levels of CML amounted to 6% of the total lesions and were higher
than AASA (1.3%) and CEL (1.2%). In the natural cycle, CEL was significantly lower (p < 0.05) than in
the stimulated cycle, suggesting that natural cycles are more protected against protein glycoxidation.
These findings are the basis for further research to elucidate the possible relevance of this follicular
biomarker of advanced glycation end product in fertility programs.
Keywords: assisted reproduction; follicular fluid; oxidative stress; aminoadipic semialdehyde;
glutamic semialdehyde; gas chromatography-mass spectrometry; female infertility
1. Introduction
Free radicals are highly reactive molecular species that are inherent to aerobic life. Proteins are
one of the major targets of free radical attack, not only because of their high concentration in all
compartments but also because some amino acids (tyrosine, methionine, arginine, proline, and lysine)
are prone to non-enzymatic modifications [1]. Proteins are involved in practically all physiological
processes, and their oxidative modifications may have detrimental effects in an organism [2,3].
A hallmark of oxidative protein damage is the introduction of carbonyl groups into amino acid
residues. Carbonyl groups in proteins may directly arise by metal-catalyzed oxidation of specific amino
acids. Alternatively, during the protein glycation and the peroxidation of polyunsaturated fatty acids,
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reactive aldehydes (methylglyoxal, glyoxal, and 4-hydroxynonenal) are formed. These compounds
react with residues of lysine in proteins generating covalent adducts, thus contributing to total
carbonylation. Therefore, the quantification of total carbonyl groups in proteins constitutes a global
marker of protein oxidation independent of the radical initiator [4,5].
Multiple residues in proteins are susceptible to non-enzymatic modifications, which presents
a challenge in undertaking the analysis, but also the possibility of getting a fingerprint. Thus,
the metal-catalyzed oxidation renders glutamic semialdehyde (GSA) and aminoadipic semialdehyde
(AASA) as main carbonyl products [6]. Lysine residues in proteins are targets for specific covalent
addition of reactive compounds derived from glucose metabolism [7] and lipid peroxidation [8].
As a consequence, the Nε-(carboxymethyl)lysine (CML) and Nε-(carboxyethyl)lysine (CEL) advanced
glycation end products (AGEs) are formed, the last one arising specifically from non-enzymatic
decomposition of glycolytic intermediates [9]. All these compounds represent specific indices of
in vivo oxidative modifications of amino acids in proteins.
Controlled ovarian stimulation with exogenous gonadotropins is generally used in assisted
reproduction in order to recover a synchronous cohort of mature oocytes and thus improve the results
of in vitro fertilization. However, the treatment involves clinical problems, such as pregnancy and
perinatal complications [10,11], multiple pregnancies [12], and ovarian hyperstimulation syndrome [13].
Ovarian hyperstimulation also causes deterioration of the quality and maturity of oocytes in
some patients, including patients with polycystic ovary syndrome (PCOS) and unexplained poor
responders [14]. The follicular fluid is the microenvironment for the developing oocyte and is
enriched in proteins. A large number of proteins have been identified in this fluid by proteomic
analysis [15–17]. More than 60% of the intrafollicular proteins have extracellular origin, and the rest
are located intracellularly or in the plasma membrane [17]. As for their molecular functions, most
proteins have catalytic activity and binding function, followed by receptor and structural functions [16].
About 50% of the follicular proteins are involved in immune activity and coagulation [17]. As indicated
above, proteins are the main targets of the attack of reactive oxygen species (ROS), and oxidative
stress could compromise their function. In a previous work, we described that controlled ovarian
stimulation led to oxidative stress, mainly reflected by changes in the redox status of the serum in
terms of total antioxidant activity, susceptibility to in vitro oxidation, and the levels of antioxidants
such as tocopherol, bilirubin, uric acid, and albumin [18]. It has been reported that oocytes derived
from natural cycles show differences from those from stimulated cycles in relevant aspects, such as
epigenetics and ultrastructural integrity [19,20]. Ovarian stimulation with exogenous gonadotropins
alters the composition of the follicular milieu [21,22]. However, the effect of the hormonal intervention
on the protein integrity is unknown. The aim of this work was to analyze biomarkers of in vivo
non-enzymatic oxidative modifications of proteins from human follicular fluid arising from specific
pathways, and the impact of ovarian stimulation on these biomarkers. The measured protein oxidation
indices were GSA and AASA, which are specific protein carbonyls from metal-catalyzed oxidations,
CEL for glycoxidation, and CML for mixed glyco- and lipoxidation.
2. Materials and Methods
2.1. Study Design and Study Population
Twenty-seven fertile women (with at least one living child) were recruited from 28 February
2014 to 16 December 2015 in the “Oocyte donor program” of the Valencian Institute of Infertility
in Bilbao (IVIRMA, www.ivi.es, Vizcaya, Spain). Women were under the age of 35, had a normal
physical examination, body mass index between 18 kg/m2 and 25 kg/m2, and normal karyotype.
Criteria for participation in the study were no history of chromosomal or genetic diseases, negative
infectious disease screening, regular menstrual cycles (26–35 days), and no history of endometriosis or
recurrent miscarriages.
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Women underwent both a cycle of controlled ovarian hyperstimulation and a natural cycle. For the
stimulated cycles, pituitary desensitization was achieved by administration of GnRH antagonists,
as described previously [23]. Briefly, women were given pretreatment with a contraceptive pill
(3 mg of drospirenone plus 0.03 mg of ethinyl estradiol (Yasmin; Schering, Madrid, Spain) during
the cycle before the scheduled oocytes retrieval. Ovarian stimulation was initiated 5 days after
pill discontinuation. A daily dose of 0.25 mg of GnRH antagonist (Cetrotide, Serono Laboratories,
Madrid, Spain) was administered on day 6 of stimulation, or when the largest follicle was at least
14 mm in diameter. GnRH antagonist administration was maintained until the induction of ovulation.
Ovarian stimulation with gonadotropins (recombinant follicle-stimulating hormone, highly purified
human menopausal gonadotropin, or a combination of both) was established for an average of nine or
ten days. Ovarian response was assessed by vaginal ultrasound examination every 2 days. Ovulation
was induced by single subcutaneous administration of a GnRH agonist (2 mg triptorelin acetate,
Gonapeptyl, Ferring S.A., Madrid, Spain) when at least three leading follicles were >17 mm in diameter.
Transvaginal oocyte retrieval was scheduled 36 h later.
For the natural cycle, follicle size was assessed by vaginal ultrasound on day 8–10 of the cycle.
Thereafter, follicular development was followed every 2 or 3 days until the follicle was between 17 and
20 mm in diameter. Then, ovulation was induced by single subcutaneous administration of triptorelin
acetate, and oocytes were retrieved 36 h later.
2.2. Ethical Approval
The Ethics Committee of the University UPV/EHU (Ethics Committee for Research involving
Human Subjects, CEISH) approved the human subject protocol (CEISH/276/2014/RUIZLARREA),
and the study was performed according to the UPV/EHU and IVI-Bilbao agreement. The project
complies with the Spanish Law of Assisted Reproductive Technologies (14/2006). Written informed
consent was obtained from all trial subjects for participation in the study.
2.3. Sample Collection
For each patient, follicular fluid from the sole follicle (natural cycle) or from two contralateral
follicles was obtained. Samples visually contaminated with blood were discarded. In the stimulated
cycle, samples of follicular fluid from the same woman were pooled. After centrifuging the samples
(3000 g for 10 min), the supernatant was collected and stored in liquid nitrogen. The samples were
taken to the University and kept at −80 ◦C until analysis.
2.4. Measurement of GSA, AASA, CML, and CEL
The oxidative modification products of proteins were determined by gas liquid chromatography
coupled to mass spectrometry (GC/MS) with selective ion monitoring, following the method described
by Pamplona et al. [24] adapted to follicular fluid. Two milliliters of chloroform:methanol (2:1 v/v,
3×) in 0.01% butylated hydroxytoluene were added to 20 µl of follicular fluid. Trichloroacetic
acid (10% final concentration) was added to precipitate proteins by centrifugation. The proteins
were reduced overnight with 1 ml of 500 mM NaBH4 (final concentration) in 0.2 M borate buffer,
pH 9.2, containing 1 drop of hexanol as an anti-foaming agent. The proteins were precipitated
by adding 1 ml of 20% trichloroacetic acid and the solution was centrifuged. The following
isotopically labelled internal standards were then added: [2H8] lysine (d8-Lys; CDN Isotopes),
[2H4]-CML, [2H4]-CEL, [2H5]-5-hydroxy-2-aminovaleric acid (HAVA) for GSA quantification,
and [2H4]-6-hydroxy-2-aminocaproic acid (HACA) for AASA quantification. The samples were
hydrolyzed at 155 ◦C for 30 min in 1 ml of 6 N HCl, and then vacuum dried. The N,O-trifluoroacetyl
methyl ester derivatives of the hydrolyzed proteins were prepared by sequential treatment with
methanolic HCl and trifluoroacetic anhydride [20]. Briefly, 1 ml of 6.5% acetyl chloride in methanol
was added to the sample, and the reaction was maintained at 65 ◦C for 30 min. After vacuum-drying,
one milliliter of trifluoroacetic anhydride was added and the reaction proceeded for 1 h at room
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temperature. The resultant N,O-trifluoroacetyl methyl ester derivatives were dried and resuspended in
dichloromethane for gas-chromatographic studies. The GC/MS analyses were carried out on an Agilent
6890N gas chromatograph equipped with a HP-5MS capillary column (30 m × 0.25 mm × 0.25 µm)
coupled to a 5973 mass selective detector (Agilent Technologies, Barcelona, Spain). The injection port
was maintained at 275 ◦C; the temperature program was set at 110 ◦C for 5 min, with the temperature
then rising by 2 ◦C/min to 150 ◦C, then by 5 ◦C/min to 240 ◦C, then by 25 ◦C/min to 300 ◦C, and finally
held at 300 ◦C for 5 min. Quantification was performed by external standardization using standard
curves constructed from mixtures of deuterated and non-deuterated standards. The compounds were
detected by selected ion-monitoring (SIM) GC/MS. The ions used were: lysine and d8-lysine, m/z 180
and 187, respectively; HAVA and d5-HAVA (stable derivatives of GSA), m/z 280 and 285, respectively;
HACA and d4-HACA (stable derivatives of AASA), m/z 294 and 298, respectively; CML and d4-CML,
m/z 392 and 396, respectively; CEL and d4-CEL, m/z 379 and 383, respectively. The amounts of products
were expressed as the ratio of µmol GSA, AASA, CEL, or CML per mol of lysine.
2.5. Glucose Measurement
Intrafollicular glucose was determined by glucose oxidase assay kit (Falcorgent GLU from A.
Menarini Diagnostics, Barcelona, Spain).
2.6. Statistical Analysis
The statistical package SPSS 24.0 (SPSS Inc., Chicago, IL, USA) was used for data analysis.
The population size analysis was performed with G*Power 3.1 software (Düsseldorf, Germany) [25].
Sample size was calculated as a function of the power level (0.8), the pre-specified significance level α
(0.05), and the population effect size to be detected with a probability of 0.95 (in this case, medium effect
size). Taking these parameters into account, a total sample size of 27 was computed. Data were
expressed as mean ± standard error of the mean (SE). Statistical significance for the differences of the
means was estimated by parametric Student’s t-test and the Wilcoxon test (non-parametric equivalent)
for paired data. The Pearson’s correlation test was used to analyze associations between quantitative
variables. The threshold for statistical significance was set to p < 0.05.
3. Results
Calibration curves for GSA, AASA, CML, CEL, and lysine were derived in order to have
quantitative data by analyzing increasing amounts of the non-deuterated compound in the presence
of a constant amount of the corresponding deuterated compound. In the case of direct oxidations
by free radicals, HAVA (for GSA quantification) and HACA (for AASA quantification) were used
as standards, since during the reduction and acid hydrolysis processing of the samples the parent
compounds are converted into HACA (GSA) and HAVA (AASA). Correlation coefficients higher than
0.998 were obtained for all the analyzed protein oxidation indices (Figure 1).
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Proteins of follicular fluid contained oxi ation products res lting from metal-catalyzed oxidation,
glycoxidation, and lipoxid tion, since the four mentioned biomarkers were detected in all the analyzed
samples (Figure 2). An analysis of their distribution revealed that th most abundant products were
those derived from metal-catalyzed oxidation, GSA and AASA (92.8% of the total measured markers).
GSA was the most abundant protein lesion (91.5%), corresponding to a mean of 5.1 altered residues
per 1000 lysines. The l vels of the other analyz d biomarkers were an order of magnitud lower than
GSA, reaching b twee 0.064 and 0.34 damag d residues per 1000 lysines. The l vels of CML, a protein
oxidation biomarker originated from glyc xidative and lipoxidative processes, amounted to 6% of the
total lesions and w re higher than the levels of AASA (1.3%) and CEL (1.2%).
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Figure 2. Biomarkers of protein oxidative modifications in follicular fluid. Values were measured
in samples from a natural cycle. Bars represent the mean + SE of the percentage of total protein
oxidative modifications.
Considering all of the measured oxidation indices in natural and stimulated cycles,
several correlations between biomarkers were observed (Figure 3). Thus, AASA was significantly
correlated with the CEL index of glycoxidative modifications of proteins (p < 0.0001). The CML
biomarker also correlated with CEL (p < 0.05).
Antioxidants 2018, 7, x FOR PEER REVIEW  7 of 13 
 192 
Figure 2. Biomarkers of protein oxidative modifications in follicular fluid. Values were measured in 193 
samples from a natural cycle. Bars represent the mean + SE of the percentage of total protein oxidative 194 
modifications. 195 
i i  all of the measured oxidation indices in natural and stimulated cycl s, several 196 
correlations between biomarkers we e observed (Figur  3). Thus, AASA was significantly correlated 197 
with the CEL index of glycoxidative modifications f proteins (p < 0.0001). The CML biomarker also 198 
correlated with CEL (p < 0.05). 199 
 200 
Figure 3. Correlations of (A) AASA and (B) CML with CEL in follicular fluid. Samples were obtained 201 
from natural and stimulated cycles. 202 
We used this methodology to determine the possible effect of controlled ovarian 203 
hyperstimulation on the protein redox status in the follicular milieu. Results revealed no differences 204 
for the metal-dependent protein modifications (Figure 4A, B), nor were the mean values for CML 205 
adducts different between the natural cycle (337 ± 18 μmol/mol Lys) and the stimulated cycle (350 ± 206 
19 μmol/mol Lys) (Figure 4C). However, the CEL content in follicular fluid from stimulated cycles 207 
was significantly higher than that from natural cycles (8%, p < 0.05, Figure 4D). 208 
0
4
8
60
80
100
%
 o
f 
to
ta
l 
b
io
m
a
rk
e
rs
GSA AASA             CML            CEL
fl
i l t l .
e used this methodology to determine the possible effect of controlled ovarian hyperstimulation
on the protein redox status in the follicular ili u. Results r vealed n differences for the
metal-dependent protein modificati ns (Figure 4A,B), no were the mean values for
a cts iffere t b tw en the natural cycle (337 ± 18 µmol/mol Lys) and the stimulated cycle
(350 ± 19 µmol/mol Lys) (Figure 4C). However, the CEL c tent in follicular fluid from stimulated
cycles was significantly higher than that from natural cycl s (8%, p < 0.05, Figure 4D).
Antioxidants 2018, 7, 176 8 of 13
Antioxidants 2018, 7, x FOR PEER REVIEW  8 of 13 
 209 
Figure 4. Biomarkers of protein oxidative modifications in follicular fluid from women undergoing 210 
both a natural cycle and a stimulated cycle. The box and whiskers graphs represent values for (A): 211 
GSA; (B): AASA; (C): CML; and (D): CEL. The box extends from the 25th to 75th percentiles. The line 212 
in the middle of the box corresponds to the median, and the whiskers are drawn down to the 5th 213 
percentile and up to the 95th percentile. Open circles represent the outliers of the distribution. Values 214 
are expressed as μmol biomarker/mol Lys residue. * p < 0.05. 215 
In view of the differences found between natural and stimulated cycles for the index of the 216 
modifications of proteins by glycoxidation, we measured glucose in follicular fluid in both cycles. 217 
Results showed that the levels of glucose were significantly higher (p < 0.05) in the natural cycle (69 218 
± 4 mg/dl) than in the stimulated cycle (59 ± 3 mg/dl). 219 
 220 
Figure 4. Biomarkers of protein oxidative modifications in follicular fluid from women undergoing
both a natural cycle and a stimulated cycle. The box and whiskers graphs represent values for (A): GSA;
(B): A SA; (C): CML; and (D): CEL. The box extends from the 25th to 75th percentiles. The line in the
middle of the box corresponds to the median, an the whiskers are drawn o to the 5th percentile
and up to the 95th percentile. Open circl s represent the outliers of the distribution. l es are
expressed a µmol biomarker/mol Lys re idue. * p < 0. 5.
In view of the differences found natural and stimulated cycles for the index of the
modifications of proteins by glycoxidation (Figure 5), we measured glucose in follicular fluid in both
cycles. Results showed that the levels of glucose were significantly higher (p < 0.05) in the natural
cycle (69 ± 4 mg/dl) than in the stimulated cycle (59 ± 3 mg/dl).
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4. Discussion
In this study, we have described the detection and quantification of specific biomarkers of
non-enzymatic oxidative modifications of follicular fluid proteins that arise by different pathways.
ROS are products of the cellular metabolic activity that at physiological concentrations play important
roles at local and systemic levels. However, non-neutralized ROS cause oxidative damage to lipids,
proteins, and nucleic acids, leading to aberrant molecular activities [26]. Oxidative damage to
proteins by ROS can result in cleavage of the polypeptide backbone, cross-linking, and modifications
of the side chains of amino acids. Various types of protein oxidative modifications are induced
directly by ROS or indirectly by reactions with secondary products of oxidative stress. Variations
in the steady-state levels of oxidatively modified proteins in vivo can be due to differences in
the rates of oxidant generation, antioxidative defenses, protein repair and degradative capacity,
or susceptibility of proteins to oxidative damage [2,27]. Our data support the presence of markers
derived from protein oxidation in follicular fluid samples from both natural and stimulated cycles
determined by gas-liquid chromatography-mass spectrometric. Other authors have reported the
presence AGE-modified proteins in follicular fluid, but the analyses were based on immunological
techniques [28,29]. The follicular fluid composition reflects metabolic processes and the hormonal
microenvironment in which the oocyte develops [30]. Besides granulosa cells, leukocytes and
macrophages can also be found in the follicular microenvironment. All of these cell types are capable
of generating ROS [31]. The expression of antioxidant enzymes in cells that synthesize steroids, such as
granulosa, thecal, and luteal cells, has also been reported [32,33]. As a consequence, the oocyte is
exposed in vivo to oxidative stress and ROS scavenging activities present in the follicular fluid.
In the present study, it was clearly shown that the steady-state content of protein carbonyls
originated from metal-catalyzed oxidation (GSA and AASA) was higher than the levels of the CEL
and CML glycoxidation products. Moreover, the intrafollicular amount of GSA, a product of the
oxidation of arginine and proline [6], was higher than that of AASA (which originates from lysine).
Taken together, these results indicate that the protein residue oxidation is highly selective and suggest
that the degree of oxidation reflected by these biomarkers depends on the amino acid composition,
their susceptibility to oxidation (directly affected by the structural characteristics and folding of
the protein), and/or the pro-oxidant stimulus. In line with our results, Temple et al. reported that
iron-induced in vitro oxidation of human albumin led to the conversion of only two of the 59 lysine
residues to AASA, and when hypochlorous acid was used as oxidizing agent five different lysine
modification sites were identified [34].
The increase in protein carbonylation may result not only from direct oxidation of the
macromolecule by free radicals but also by the involvement of reactive dicarbonyl compounds such
as glyoxal and methylglyoxal. These compounds originate during the triose phosphate metabolism,
by lipid peroxidation and by myeloperoxidase-dependent reactions [35,36]. Electrophilic aldehydes
are well-known by-products of the non-enzymatic peroxidation of polyunsaturated fatty acids, usually
arachidonic and linoleic acids, and are also formed from glycolytic intermediates. These aldehydes
are highly reactive with protein residues of histidine, cysteine, and lysine, forming Michael’s adducts,
which may result in impairment of enzyme activities and interference with signaling pathways [37–39].
Amino acid residues, such as lysine, can be modified by adduct formation with aldehydes derived
from the peroxidation of polyunsaturated fatty acids, particularly aldehydes with α, β-unsaturated
functional groups [40]. Among them, glyoxal, a precursor to CML, yields chemically stable adducts
with lysine residues. CML was initially described as a product of carbohydrate autoxidation, but it is
now well documented that it is also a compound derived from lipid peroxidation in the presence of
proteins, and its amount depends on the degree of unsaturation and oxidizability of fatty acids [41].
We have detected CML in the follicular fluid of women at a concentration about 10-fold lower than the
metal-dependent modifications.
Neither the CML nor the GSA and AASA levels in the follicular fluid were modified as a
consequence of controlled ovarian stimulation. By contrast, we observed a higher content of CEL
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in follicular fluid from stimulated cycles. We do not know the physiological relevance of this 8%
increase, although a similar increase of CEL has been reported in brain cortex samples from patients
with Alzheimer’s disease [24]. It is still not known whether the damaged proteins associated with
this marker have specific functions in the reproductive process. AGEs in the follicular fluid not only
represent a loss of function of those AGE-modified proteins but are also an additional source of
ROS. AGEs circulate in the medium (i.e., follicular fluid) and bind to plasma membrane receptors,
such as the receptor for AGEs (RAGE), which is a member of the immunoglobulin superfamily of
receptors [42]. The AGE/RAGE interaction activates the nuclear factor kappa-B and other downstream
pathways, resulting in production of ROS and pro-diabetic, pro-inflammatory, pro-thrombotic,
and pro-atherogenic responses [8]. In a recent study, a proteome analysis of follicular fluid from
natural and stimulated cycles revealed that eight proteins were differentially expressed in stimulated
cycles [43]. The upregulated proteins were related to immune and inflammatory responses, suggesting
that these processes might play a role in the adverse effects of ovarian hyperstimulation. The treatment
with exogenous gonadotropins leading to multiple oocyte retrieval would contribute to ROS increase,
and consequently their detrimental effects on proteins.
The CEL increase in the stimulated cycle was accompanied by a substantial reduction in follicular
glucose levels. This decrease could be due to the fact that the sugar is being metabolized to
intermediates that generate methylglyoxal, which reacts with intrafollicular proteins, thus forming
stable adducts. The ovarian stimulation protocol has been shown to alter the intrafollicular levels
of hormones associated with fertility parameters, in particular estradiol, luteinizing hormone,
and anti-Müllerian hormone. The treatment with exogenous gonadotropins reduced these hormones,
reflecting poorer outcomes of oocyte maturation and quality, and embryo implantation [21]. It is
unknown whether the hormonal alterations are related to the changes observed in CEL levels or if
they are independent factors that may contribute to the in vitro fertilization (IVF) outcomes.
The present work is a pilot study. If the results are validated using a larger sample size,
the measurement of CEL could have implications in assisted reproduction. The identification of
the specific glycoxidatively modified proteins and the knowledge of the associated functional changes
in fertility parameters are a subject of research to develop. The information derived from those data
could result in direct implications for the techniques and outcomes of assisted reproduction. It also
remains to be established whether similar changes are reflected in other biological fluids, such as blood.
5. Conclusions
The GC/MS method described in this article provides a means for the specific quantification of
CEL and CML adducts and oxidative modifications of amino acids (GSA and AASA) occurring in
follicular fluid proteins. Differences between the natural and stimulated cycles were found for the
CEL glycoxidation-modified protein biomarker, with the lowest index observed for the natural cycle.
These findings are the basis for future research and open new perspectives for establishing the possible
relevance that this intrafollicular biomarker of in vivo protein modifications has in determining success
of IVF in assisted reproduction programs.
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